Trill AB - 23 Jul 2025 SCHEDULE 13G/A Report for DiaMedica Therapeutics Inc. Common Shares, no par value (DMAC)

Filing Manager: Trill AB
Reporting Manager: Trill AB
Security: DiaMedica Therapeutics Inc. Common Shares, no par value
Symbol: DMAC
Shares outstanding: 51,479,947 shares
Disclosed Ownership: 6,764,465 shares
Ownership: 13.1%
Form type: SCHEDULE 13G/A
Filing time: 30 Jul 2025, 17:33:29 UTC
Date of event: 23 Jul 2025
Next filing: 04 Sep 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Trill AB	13.1%	6,764,465	0	6,764,465	/s/ Jan Stahlberg	Jan Stahlberg/Board Member
Jan Stahlberg	13.1%	6,764,465	0	6,764,465	/s/ Jan Stahlberg	Jan Stahlberg